Inventor · disambiguated record
Shengwen Li
Also filed as: LI SHENGWEN
20 granted patents·11 pending applications·549 citations·filing 2003–2013
96Inventor score
Top patents by PatentIndex Score
31 records- 0199US7897157B2Activatable clostridial toxinsALLERGAN INC·Filed 2007·Granted Mar 1, 2011·62 cites·29 claims
- 0299US7749514B2Activatable clostridial toxinsALLERGAN INC·Filed 2007·Granted Jul 6, 2010·64 cites·19 claims
- 0398US7811584B2Multivalent clostridial toxinsALLERGAN INC·Filed 2008·Granted Oct 12, 2010·79 cites·12 claims
- 0498US7740868B2Activatable clostridial toxinsALLERGAN INC·Filed 2007·Granted Jun 22, 2010·63 cites·34 claims
- 0597US8071110B2Activatable clostridial toxinsSTEWARD LANCE E·Filed 2008·Granted Dec 6, 2011·32 cites·13 claims
- 0695US8623999B2Modified Clostridial toxins with enhanced targeting capabilities for endogenous Clostridial toxin receptor systemsSTEWARD LANCE E·Filed 2012·Granted Jan 7, 2014·27 cites·3 claims
- 0795US8052979B2Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cellsALLERGAN INC·Filed 2006·Granted Nov 8, 2011·30 cites·16 claims
- 0894US8128940B2Modified clostridial toxins with enhanced targeting capabilities for endogenous clostridial toxin receptor systemsSTEWARD LANCE E·Filed 2006·Granted Mar 6, 2012·25 cites·5 claims
- 0994US7993656B2Modified clostridial toxins with enhanced translocation capabilities and altered targeting activity for clostridial toxin target cellsALLERGAN INC·Filed 2007·Granted Aug 9, 2011·22 cites·5 claims
- 1093US8273358B2Activatable clostridial toxinsSTEWARD LANCE E·Filed 2008·Granted Sep 25, 2012·11 cites·9 claims
- 1193US8021859B2Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cellsALLERGAN INC·Filed 2008·Granted Sep 20, 2011·19 cites·13 claims
- 1293US7892565B2Degradable clostridial toxinsALLERGAN INC·Filed 2005·Granted Feb 22, 2011·19 cites·29 claims
- 1392US7998489B2Degradable clostridial toxinsALLERGAN INC·Filed 2008·Granted Aug 16, 2011·17 cites·2 claims
- 1491US8518417B1Modified clostridial toxins with enhanced translocation capability and enhanced targeting activitySTEWARD LANCE E·Filed 2007·Granted Aug 27, 2013·14 cites·1 claims
- 1591US8273865B2Multivalent clostridial toxinsSTEWARD LANCE E·Filed 2010·Granted Sep 25, 2012·8 cites·13 claims
- 1689US7825233B2Optimizing expression of active Botulinum Toxin type EALLERGAN INC·Filed 2005·Granted Nov 2, 2010·13 cites·5 claims
- 1789US7172764B2Rescue agents for treating botulinum toxin intoxicationsALLERGAN INC·Filed 2003·Granted Feb 6, 2007·32 cites·16 claims
- 1886US8460682B2Modified clostridial toxins with altered targeting capabilities for clostridial toxin target cellsSTEWARD LANCE E·Filed 2011·Granted Jun 11, 2013·6 cites·13 claims
- 1969US6991789B2Methods of modulating intracellular degradation rates of toxinsALLERGAS INC·Filed 2004·Granted Jan 31, 2006·5 cites·4 claims
- 2061US8198083B1Organotypic slices of the central nervous systemLOUDON WILLIAM GUNTER·Filed 2008·Granted Jun 12, 2012·1 cites·10 claims
- 2158US2009023198A1Optimizing expression of active botulinum toxin type aALLERGAN INC·Filed 2008·Application pending·0 cites
- 2255US2005169942A1Novel DNA sequences of the botulinum neurotoxin complex of Clostridium botulinum type A-Hall (Allergan) strain for production of therapeuticsALLERGAN INC·Filed 2004·Application pending·0 cites
- 2355US2006024794A1Novel methods for production of di-chain botulinum toxinLI SHENGWEN·Filed 2004·Application pending·0 cites
- 2452US2011294742A1Degradable clostridial toxinsSTEWARD LANCE E·Filed 2011·Application pending·0 cites
- 2552US2006257430A1Methods of modulating intracellular degradation rates of toxinsALLERGAN INC·Filed 2005·Application pending·0 cites
- 2652US2009018081A1Activatable clostridial toxinsALLERGAN INC·Filed 2008·Application pending·0 cites
- 2752US2013345413A1Modified clostridial toxins with enhanced translocation capabilitiyALLERGAN INC·Filed 2013·Application pending·0 cites
- 2850US2008032931A1Activatable clostridial toxinsSTEWARD LANCE E·Filed 2007·Application pending·0 cites
- 2949US2008057575A1Optimizing Expression of Active Botulinum Toxin Type AALLERGAN INC·Filed 2005·Application pending·0 cites
- 3046US2005129677A1Lipid rafts and clostridial toxinsFiled 2003·Application pending·0 cites
- 3138US2011111483A1Optimizing Expression of Active Botulinum Toxin Type EALLERGAN INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shengwen Li files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →